15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
10-K/A: Annual report (Amendment)
8-K/A: Current report (Amendment)
10-K: Annual report
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Ayala Pharmaceuticals | 8-K: Current report
Ayala Pharmaceuticals | NT 10-K: Others
Ayala Pharmaceuticals | 8-K: Current report
Ayala Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Israel Biotech Fund I, L.P.
Ayala Pharmaceuticals | 8-K: Current report
Ayala Pharmaceuticals | DEFM14C: Others
Ayala Pharmaceuticals | 8-K: Current report